Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate CancerSantosh Gupta, Jing Li, Gabor Kemeny, et al.
Clinical Journal of Oncology Nursing|May 23, 2015
Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institutionKristen Davis, Sarah Wood, Emily Dill, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 1999
Gene expression in the brain across the hibernation cycleB F O'Hara, F L Watson, H K Srere, et al.
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
JCO Precision Oncology|May 15, 2025
Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) SurveyRhonda L Bitting, Christopher McNair, Alexander W Wyatt, et al.
Cardio-Oncology (London, England)|February 6, 2025
Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort studyAlexander R Lucas, Dustin Bastiach, Bassam Dahman, et al.
Journal of Geriatric Oncology|March 29, 2023
Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trialHeidi D Klepin, Janet A Tooze, Rhonda L Bitting, et al.
Cancer Research Communications|February 12, 2024
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial CarcinomaRhonda L Bitting, Janet A Tooze, Michael Goodman, et al.
Molecular Cancer Research : MCR|June 14, 2011
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markersAndrew J Armstrong, Matthew S Marengo, Sebastian Oltean, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access SettingDavid J Carpenter, Divya Natesan, R Warren Floyd, et al.
Pageof 7